COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Naseri, Mohammad Hassan, Madani, Hoda, Ahmadi Tafti, Seyed Hossein, Moshkani Farahani, Maryam, Kazemi Saleh, Davood, Hosseinnejad, Hossein, Hosseini, Saeid, Hekmat, Sepideh, Hossein Ahmadi, Zargham, Dehghani, Majid, Saadat, Alireza, Mardpour, Soura, Hosseini, Seyedeh Esmat, Esmaeilzadeh, Maryam, Sadeghian, Hakimeh, Bahoush, Gholamreza, Bassi, Ali, Amin, Ahmad, Fazeli, Roghayeh, Sharafi, Yaser, Arab, Leila, Movahhed, Mansour, Davaran, Saeid, Ramezanzadeh, Narges, Kouhkan, Azam, Hezavehei, Ali, Namiri, Mehrnaz, Kashfi, Fahimeh, Akhlaghi, Ali, Sotoodehnejadnematalahi, Fattah, Vosough Dizaji, Ahmad, Gourabi, Hamid, Syedi, Naeema, Shahverdi, Abdolhosein, Baharvand, Hossein, Aghdami, Nasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005993/
https://www.ncbi.nlm.nih.gov/pubmed/29845801
http://dx.doi.org/10.22074/cellj.2018.6018
Mostrar todas las versiones(2)

Ejemplares similares